AuditLine › HHS OIG › Substance Abuse and Mental Health Services Administration
HHS OIG recommendation 21-E-BL-027.01
SAMHSA should develop comprehensive methods and measures to assess access to medication-assisted treatment via waivered providers.
The recommendation, in the publisher's words
SAMHSA should develop comprehensive methods and measures to assess access to medication-assisted treatment via waivered providers.
- Responsible agency
- Substance Abuse and Mental Health Services Administration
- Issued
- June 14, 2021
- Report
- SAMHSA Is Missing Opportunities To Better Monitor Access to Medication Assisted Treatment Through the Buprenorphine Waiver Program (OEI-BL-20-00260) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Concur (as recorded by the publisher)
- Closed
- January 12, 2023 (publisher's date)
- Publisher topics
- Substance Abuse Disorder
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Acceptable Alternative”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.